Sort   by:  
 Page size 
UnknownG-rich oligonucleotides inhibit HIF-1alpha and HIF-2alpha and block tumor growth.
Not available
S-EPMC2839212 | biostudies-literature
UnknownRe-evaluation of binding properties of recombinant lymphocyte receptors NKR-P1A and CD69 to chemically synthesized glycans and peptides.
Not available
S-EPMC3907868 | biostudies-literature
UnknownSubstituted Piperazines as Novel Potential Radioprotective Agents.
Not available
S-EPMC7038073 | biostudies-literature
UnknownCDK6 as a key regulator of hematopoietic and leukemic stem cell activation.
Not available
S-EPMC4281832 | biostudies-literature
UnknownSTAT5BN642H is a driver mutation for T cell neoplasia.
Not available
S-EPMC5749501 | biostudies-literature
UnknownEfficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I.
Not available
S-EPMC4380721 | biostudies-literature
UnknownA pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis.
Not available
S-EPMC4800694 | biostudies-literature
Sort   by:  
 Page size